Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …

Approximately 800 people are diagnosed with osteosarcoma (OSA) per year in the USA.
Although 70% of patients with localized OSA are cured with multiagent chemotherapy and …

Osteosarcoma (OS) is the most common non-hematologic primary tumor of bone in children
and adults. High-dose cytotoxic chemotherapy and surgical resection have improved …

Osteosarcoma is a malignant mesenchymal neoplasm that accounts for the majority of
primary bone tumors in dogs and shares biological and clinical similarities with …

Abstract Since the great Rudolf Virchow advised,“Between animal and human medicine
there is no dividing line, nor should there be,” limited attention has been paid to cancer in …

Canine osteosarcoma (OSA) is an aggressive malignancy, sharing biological and clinical
similarities with the human counterpart. The prognosis of patients with high-grade OSA still …

Appendicular osteosarcoma (OS) is a primary mesenchymal tumor arising from malignantly
transformed osteoblasts. In people, OS is the most common nonhematopoietic, primary …

Cancer is a leading cause of non-communicable morbidity and mortality throughout the
world, similarly, in dogs, the most frequent cause of mortality is tumors. Some types of …

After spending the bulk of my professional career studying the biology of osteosarcoma
(OS), it is with great pleasure that I take this opportunity to serve as a guest editor to this …

摘要： 迄今为止， 开发新的骨肉瘤治疗策略的努力未能改变其肿瘤学结局，
尤其是对转移性骨肉瘤患者。 我们继续寻找新的疾病模型以开发新的治疗方法迫在眉睫 …